571 / 1726
GUSTAVE ROUSSY
THÈME DU DIAPORAMA
Significant heterogeneity among the trials
May be inappropriate to combine the trials
Trials divided in two ways:
Cycle interval (> 14 d vs ≤ 14 d)
Cisplatin dose intensity (< 25 vs ≥ 25 mg/m
2
/wk)
Comparison 1
NACT followed by RT vs RT